Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

Pancreatic and Hepatobiliary Cancers

Dr Caio Max Rocha Lima - Wake Forest Baptist Health, North Carolina, USA

Pancreatic and Hepatobiliary Cancers ( Dr Caio Max Rocha Lima - Wake Forest Baptist Health, North Carolina, USA )

Oesophageal and gastric cancers

Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA

Oesophageal and gastric cancers ( Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA )

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment

Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment ( Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel )

OncoAlert and ecancer weekly round up for July 19 - July 25, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 19 - July 25, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Part 4: Metastatic prostate cancer and HRR defects

PARP inhibition in the treatment of prostate cancer

Part 4: Metastatic prostate cancer and HRR defects ( PARP inhibition in the treatment of prostate cancer )

Part 5: BRCA 1/2 mutations and prostate cancer

PARP inhibition in the treatment of prostate cancer

Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC...

Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021 ( Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China )

Lineage plasticity in lung cancer- biological and therapeutic implications

Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA

Lineage plasticity in lung cancer- biological and therapeutic implications ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration...

Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell...

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) ( Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, USA )

Cell free DNA BRAF mutant allele fraction and whole exome sequencing in...

Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain

$Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer ( Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain )$

OncoAlert and ecancer weekly round up for July 1- July 10, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 1- July 10, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R...

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R B-cell acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )

More from ecancer